VBI Vaccines seems to be fairly valued based on Macroaxis valuation methodology. Our model measures the value of VBI Vaccines from examining the entity fundamentals such as Retained Earnings of (582.45 M), revenue of 8.68 M, and Net Income of (92.84 M) as well as evaluating its technical indicators and probability of bankruptcy.
Fairly Valued
Today 0.0005
Please note that VBI Vaccines' price fluctuation is out of control at this time. Calculation of the real value of VBI Vaccines is based on 3 months time horizon. Increasing VBI Vaccines' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
VBI Vaccines' intrinsic value may or may not be the same as its current market price of 0.0005, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical
Market 5.0E-4
Real 4.8E-4
Hype 5.21E-4
Naive 0.001642
The intrinsic value of VBI Vaccines' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence VBI Vaccines' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of VBI Vaccines helps investors to forecast how VBI stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of VBI Vaccines more accurately as focusing exclusively on VBI Vaccines' fundamentals will not take into account other important factors:
VBI Vaccines is at this time anticipated to have takeover price of 0 with market capitalization of 0, debt of 50.77 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the VBI Vaccines fundamentals before making investing decisions based on enterprise value of the company
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of VBI connotes not a very effective usage of assets in December.
Covid
VBI Vaccines Profitability Analysis
The company reported the revenue of 8.68 M. Net Loss for the year was (92.84 M) with profit before overhead, payroll, taxes, and interest of 0.
About VBI Vaccines Valuation
The stock valuation mechanism determines VBI Vaccines' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of VBI Vaccines based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of VBI Vaccines. We calculate exposure to VBI Vaccines's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of VBI Vaccines's related companies.
Investing in growth stocks can be very risky. If the company such as VBI Vaccines does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding
23.9 M
Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.